Aminocarbonylcarbamate compounds
AssigneeSK Biopharmaceuticals Co., Ltd.
InventorsYoung-Soon Kang, Jin-Yong Chung, Cheol-Young Maeng, Han-Ju Yi, Ki-Ho Lee, Joon Heo, Eun-Hee Chae, Yu-Jin Shin
Life of this patent
Estimating the term…
Abstract
The present disclosure provides a compound represented by Formula (I) and a pharmaceutically acceptable salt which are effective as a dopamine reuptake inhibitor and a method of using the compound: wherein X is independently halo, alkyl, alkoxy or nitro; m is 0, 1, 2, 3 or 4; n is 1 or 2; R1 and R2 are independently H— or alkyl; R3 is H—, alkyl or aralkyl; and R4 is H— or aryl.
Claims18
A compound of 2-amino-3-phenylpropyl(aminocarbonyl)carbamate or a pharmaceutically acceptable salt or stereoisomer thereof.
A method for inhibiting dopamine reuptake comprising:
- administrating to a subject in need thereof a therapeutically effective amount of 2-amino-3-phenylpropyl(aminocarbonyl)carbamate or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.